For many years, only two major categories of pulmonary neuroendocrine tumors were recognized: the carcinoid tumor and smallcell lung carcinoma (SCLC). In 1972, Arrigoni et al. (1972) proposed pathologic criteria for the atypical carcinoid tumor. Atypical carcinoids have more evident cytologic atypia, cellularity, focal necrosis, and increased mitotic activity (between 5 and 10 mitoses per 10 high-power fields) than typical carcinoid tumors, and the clinical aggressiveness of atypical carcinoid is less than that of SCLC. Since then, neuroendocrine tumors of the lung have been classified into three categories: typical carcinoid, atypical carcinoid, and SCLC. In recent years, it has become apparent that a large variety of pulmonary neuroendocrine tumors exist and that some tumors cannot be easily classified into one of these three categories. Several new categories have been proposed such as neuroendocrine carcinoma of intermediate sized cells, largecell neuroendocrine tumor of the lung, peripheral small-cell carcinoma of the lung resembling carcinoid tumor, and nonsmall cell lung carcinoma (NSCLC) with neuroendocrine features. In 1991, large cell neuroendocrine carcinoma (LCNEC) was proposed for the fourth high-grade neuroendocrine tumor of the lung (Travis et al., 1991).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Araki, K., Ishii, G., Yokose, T., Nagai, K., Funai, K., Kodama, K., Nishiwaki, Y., and Ochiai, A. 2003. Frequent overexpression of the c-kit protein in large cell neuroendocrine carcinoma of the lung. Lung Cancer 40: 173–180
Arrigoni, M.G., Woolner, L.B., and Bernatz, P.E. 1972. Atypical carcinoid tumors of the lung. J. Thorac. Cardiovasc. Surg. 64: 413–421
Asamura, H., Kameya, T., Matsuno, Y., Noguchi, M., Tada, H., Ishikawa, Y., Yokose, T., Jiang, S.X., Inoue, T., Nakagawa, K., Tajima, K., and Nagai, K. 2006. Neuroendocrine neoplasms of the lung: a prognostic spectrum. J. Clin. Oncol. 24: 70–76
Broers, J.L., Rot, M.K., Oostendorp, T., Huysmans, A., Wagenaar, S.S., Wiersma-van Tilburg, A.J., Vooijs, G.P., and Ramaekers, F.C. 1987. Immunocytochemical detection of human lung cancer heterogeneity using antibodies to epithelial, neuronal, and neuroendocrine antigens. Cancer Res. 47: 3225–3234
Casali, C., Stefani, A., Rossi, G., Migaldi, M., Bettelli, S., Parise, A., and Morandi, U. 2004. The prognostic role of c-kit protein expression in resected large cell neuroendocrine carcinoma of the lung. Ann. Thorac. Surg. 77: 247–252
Dresler, C.M., Ritter, J.H., Patterson, G.A., Ross, E., Bailey, M.S., and Wick, M.R. 1997. Clinical-pathologic analysis of 40 patients with large cell neuroendocrine carcinoma of the lung. Ann. Thorac. Surg. 63: 180–185
Folpe, A.L., Gown, A.M., Lamps, L.W., Garcia, R., Dail, D.H., Zarbo, R.J., and Schmidt, R.A. 1999. Thyroid transcription factor-1: immuno-histochemical evaluation in pulmonary neuroen-docrine tumors. Mod. Pathol. 12: 5–8
Govindan, R., Page, N., Morgensztern, D., Read, W., Tierney, R., Vlahiotis, A., Spitznagel, E.L., and Piccirillo, J. 2006. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J. Clin. Oncol. 24: 4539–4544
Gugger, M., Burckhardt, E., Kappeler, A., Hirsiger, H., Laissue, J.A., and Mazzucchelli, L. 2002. Quantitative expansion of structural genomic alterations in the spectrum of neuroendocrine lung carcinomas. J. Pathol. 196: 408–415
Guinee, D.G. Jr, Fishback, N.F., Koss, M.N., Abbondanzo, S.L., and Travis, W.D. 1994. The spectrum of immunohistochemical staining of small-cell lung carcinoma in specimens from transbronchial and open-lung biopsies. Am. J. Clin. Pathol. 102: 406–414
Hiroshima, K., Iyoda, A., Shibuya, K., Haga, Y., Toyozaki, T., Iizasa, T., Nakayama, T., Fujisawa, T., and Ohwada, H. 2004. Genetic alterations in early-stage pulmonary large cell neuroendocrine carcinoma. Cancer 100: 1190–1198
Hiroshima, K., Iyoda, A., Shida, T., Shibuya, K., Iizasa, T., Kishi, H., Tanizawa, T., Fujisawa, T., and Nakatani, Y. 2006. Distinction of pulmonary large cell neuroendocrine carcinoma from small cell lung carcinoma: a morphological, immu-nohistochemical, and molecular analysis. Mod. Pathol. 19: 1358–1368
Iyoda, A., Hiroshima, K., Toyozaki, T., Haga, Y., Fujisawa, T., and Ohwada, H. 2001a. Clinical characterization of pulmonary large cell neu-roendocrine carcinoma and large cell carcinoma with neuroendocrine morphology. Cancer 91: 1992–2000
Iyoda, A., Hiroshima, K., Toyozaki, T., Haga, Y., Baba, M., Fujisawa, T., and Ohwada, H. 2001b. Adjuvant chemotherapy for large cell carcinoma with neuroendocrine features. Cancer 92: 1108–1112
Iyoda, A., Hiroshima, K., Baba, M., Saitoh, Y., Ohwada, H., and Fujisawa, T. 2002. Pulmonary large cell carcinomas with neuroendocrine features are high-grade neuroendocrine tumors. Ann. Thorac. Surg. 73: 1049–1054
Iyoda, A., Hiroshima, K., Moriya, Y., Sekine, Y., Shibuya, K., Iizasa, T., Nakatani, Y., and Fujisawa, T. 2006a. Prognostic impact of large cell neuroen-docrine histology in patients with pathologic stage Ia pulmonary non-small cell carcinoma. J. Thorac. Cardiovasc. Surg. 132: 312–315
Iyoda, A., Hiroshima, K., Moriya, Y., Takiguchi, Y., Sekine, Y., Shibuya, K., Iizasa, T., Kimura, H., Nakatani, Y., and Fujisawa, T. 2006b. Prospective study of adjuvant chemotherapy for pulmonary large cell neuroendocrine carcinoma. Ann. Thorac. Surg. 82: 1802–1807
Iyoda, A., Hiroshima, K., Nakatani, Y., and Fujisawa, T. 2007. Pulmonary large cell neuroendocrine carcinoma: its place in the spectrum of pulmonary carcinoma. Ann. Thorac. Surg. 84: 702–707
Jerome Marson, V., Mazieres, J., Groussard, O., Garcia, O., Berjaud, J., Dahan, M., Carles, P., and Daste, G. 2004. Expression of TTF-1 and cytokeratins in primary and secondary epithelial lung tumours: correlation with histological type and grade. Histopathology 45: 125–134
Jiang, S.X., Kameya, T., Sato, Y., Yanase, N., Yoshimura, H., and Kodama, T. 1996. Bcl-2 pro-tein expression in lung cancer and close correlation with neuroendocrine differentiation. Am. J. Pathol. 148: 837–846
Jiang, S.X., Kameya, T., Shinada, J., and Yoshimura, H. 1999. The significance of frequent and independent p53 and bcl-2 expression in large-cell neuroendocrine carcinomas of the lung. Mod. Pathol. 12: 362–369
Jiang, S.X., Kameya, T., Asamura, H., Umezawa, A., Sato, Y., Shinada, J., Kawakubo, Y., Igarashi, T., Nagai, K., and Okayasu, I. 2004. hASH1 expression is closely correlated with endocrine phenotype and differentiation extent in pulmonary neuroendo-crine tumors. Mod. Pathol. 17: 222–229
Jones, M.H., Virtanen, C., Honjoh, D., Miyoshi, T., Satoh, Y., Okumura, S., Nakagawa, K., Nomura, H., and Ishikawa, Y. 2004. Two prognostically significant subtypes of high-grade lung neuroen-docrine tumours independent of small-cell and large-cell neuroendocrine carcinomas identified by gene expression profiles. Lancet 363: 775–781
Kaufmann, O., and Dietel, M. 2000. Expression of thyroid transcription factor-1 in pulmonary and extrapulmonary small cell carcinomas and other neuroendocrine carcinomas of various primary sites. Histopathology 36: 415–420
Kontogianni, K., Nicholson, A.G., Butcher, D., and Sheppard, M.N. 2005. CD56: a useful tool for the diagnosis of small cell lung carcinomas on biopsies with extensive crush artefact. J. Clin. Pathol. 58: 978–980
Marchevsky, A.M., Gal, A.A., Shah, S., and Koss, M.N. 2001. Morphometry confirms the presence of considerable nuclear size overlap between “small cells” and “large cells” in high-grade pulmonary neuroendocrine neoplasms. Am. J. Clin. Pathol. 116: 466–472
Nicholson, S.A., Beasley, M.B., Brambilla, E., Hasleton, P.S., Colby, T.V., Sheppard, M.N., Falk, R., and Travis, W.D. 2002. Small cell lung carcinoma (SCLC): a clinicopathologic study of 100 cases with surgical specimens. Am. J. Surg. Pathol. 26: 1184–1197
Nitadori, J., Ishii, G., Tsuta, K., Yokose, T., Murata, Y., Kodama, T., Nagai, K., Kato, H., and Ochiai, A. 2006. Immunohistochemical differential diagnosis between large cell neuroen-docrine carcinoma and small cell carcinoma by tissue microarray analysis with a large antibody panel. Am. J. Clin. Pathol. 125: 682–692
Onuki, N., Wistuba, I.I., Travis, W.D., Virmani, A.K., Yashima, K., Brambilla, E., Hasleton, P., and Gazdar, A.F. 1999. Genetic changes in the spectrum of neuroendocrine lung tumors. Cancer 85: 600–607
Pelosi, G., Masullo, M., Leon, M.E., Veronesi, G., Spaggiari, L., Pasini, F., Sonzogni, A., Iannucci, A., Bresaola, E., and Viale, G. 2004. CD117 immunoreactivity in high-grade neuroendocrine tumors of the lung: a comparative study of 39 large-cell neuroendocrine carcinomas and 27 surgically resected small-cell carcinomas. Virchows Arch. 445: 449–455
Pelosi, G., Rodriguez, J., Viale, G., and Rosai, J. 2005. Typical and atypical pulmonary carcinoid tumor overdiagnosed as small-cell carcinoma on biopsy specimens: a major pitfall in the management of lung cancer patients. Am. J. Surg. Pathol. 29: 179–187
Peng, W.X., Shibata, T., Katoh, H., Kokubu, A., Matsuno, Y., Asamura, H., Tsuchiya, R., Kanai, Y., Hosoda, F., Sakiyama, T., Ohki, M., Imoto, I., Inazawa, J., and Hirohashi, S. 2005. Array-based comparative genomic hybridization analysis of high-grade neuroendocrine tumors of the lung. Cancer Sci. 96: 661–667
Przygodzki, R.M., Finkelstein, S.D., Langer, J.C., Swalsky, P.A., Fishback, N., Bakker, A., Guinee, D.G., Koss, M., and Travis, W.D. 1996. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neu-roendocrine tumors. Correlation with histologi-cal subtype and clinical outcome. Am. J. Pathol. 148: 1531–1541
Rossi, G., Cavazza, A., Marchioni, A., Longo, L., Migaldi, M., Sartori, G., Bigiani, N., Schirosi, L., Casali, C., Morandi, U., Facciolongo, N., Maiorana, A., Bavieri, M., Fabbri, L.M., and Brambilla, E. 2005. Role of chemotherapy and the receptor tyrosine kinases KIT, PDGFRalpha, PDGFRbeta, and Met in large-cell neuroendo-crine carcinoma of the lung. J. Clin. Oncol. 23: 8774–8785
Rusch, V.W., Klimstra, D.S., and Venkatraman, E.S. 1996. Molecular markers help characterize neuroendocrine lung tumors. Ann. Thorac. Surg. 62: 798–810
Sekido, Y., Obata, Y., Ueda, R., Hida, T., Suyama, M., Shimokata, K., Ariyoshi, Y., and Takahashi, T. 1991. Preferential expression of c-kit pro-tooncogene transcripts in small cell lung cancer. Cancer Res. 51: 2416–2419
Sturm, N., Rossi, G., Lantuejoul, S., Papotti, M., Frachon, S., Claraz, C., Brichon, P.Y., Brambilla, C., and Brambilla, E. 2002. Expression of thyroid transcription factor-1 in the spectrum of neuroendocrine cell lung proliferations with special interest in carcinoids. Hum. Pathol. 33: 175–182
Takei, H., Asamura, H., Maeshima, A., Suzuki, K., Kondo, H., Niki, T., Yamada, T., Tsuchiya, R., and Matsuno, Y. 2002. Large cell neuroen-docrine carcinoma of the lung: a clinicopatho-logic study of eighty-seven cases. J. Thorac. Cardiovasc. Surg. 124: 285–292
Travis, W.D., Linnoila, R.I., Tsokos, M.G., Hitchcock, C.L., Cutler, G.B. Jr, Nieman, L., Chrousos, G., Pass, H., and Doppman, J. 1991. Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. Am. J. Surg. Pathol. 15: 529–553
Travis, W.D., Gal, A.A., Colby, T.V., Klimstra, D.S., Falk, R., and Koss, M.N. 1998. Reproducibility of neuroendocrine lung tumor classification. Hum. Pathol. 29: 272–279
Ullmann, R., Petzmann, S., Sharma, A., Cagle, P.T., and Popper, H.H. 2001. Chromosomal aberrations in a series of large-cell neuroendo-crine carcinomas: unexpected divergence from small-cell carcinoma of the lung. Hum. Pathol. 32: 1059–1063
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Science + Business Media B.V
About this chapter
Cite this chapter
Hiroshima, K. (2008). Pathological Distinction of Pulmonary Large Cell Neuroendocrine Carcinoma from Small-Cell Lung Carcinoma Using Immunohistochemistry. In: Hayat, M.A. (eds) General Methods and Overviews, Lung Carcinoma and Prostate Carcinoma. Methods of Cancer Diagnosis, Therapy, and Prognosis, vol 2. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-8442-3_25
Download citation
DOI: https://doi.org/10.1007/978-1-4020-8442-3_25
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-8441-6
Online ISBN: 978-1-4020-8442-3
eBook Packages: MedicineMedicine (R0)